Rituximab and Belimumab Combination Therapy in PR3 Vasculitis

Clinical trial NCT03967925 · UNKNOWN

Trial details

NCT number: NCT03967925
Sponsor: Rachel Jones
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

ANCA Associated Vasculitis Granulomatosis With Polyangiitis

Start date: 2019-02-01
Primary completion: 2023-04-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.